deltatrials
Completed OBSERVATIONAL NCT03037957

A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients

Sponsor: Luminex Corporation

Updated 7 times since 2017 Last updated: Jul 5, 2017 Started: Jan 9, 2017 Primary completion: Jun 2, 2017 Completion: Jun 2, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pharyngitis Bacterial, this trial is completed. The trial is conducted by Luminex Corporation and has accumulated 7 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotWithheld~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

Show 2 earlier versions
  1. Aug 2017 — Apr 2018 [monthly]

    Completed NA

    Status: WithheldCompleted

  2. Feb 2017 — Aug 2017 [monthly]

    Withheld NA

    First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Luminex Corporation
Data source: Luminex Molecular Diagnostics

For direct contact, visit the study record on ClinicalTrials.gov .